Insider Transactions in Q3 2022 at Crispr Therapeutics Ag (CRSP)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 28
2022
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
25,000
-3.99%
|
$1,600,000
$64.78 P/Share
|
|
Sep 28
2022
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+7.35%
|
$400,000
$16.21 P/Share
|
|
Aug 29
2022
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.67%
|
$1,650,000
$66.92 P/Share
|
|
Aug 29
2022
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+7.35%
|
$400,000
$16.21 P/Share
|
|
Jul 27
2022
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
25,000
-1.36%
|
$1,900,000
$76.63 P/Share
|
|
Jul 27
2022
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+3.87%
|
$350,000
$14.39 P/Share
|